Results 271 to 280 of about 243,255 (308)

METHOTREXATE IMPURITIES

The Lancet, 1972
openaire   +2 more sources

Methotrexate see Azathioprine/methotrexate

Reactions, 1989
openaire   +1 more source

Methotrexate Pharmacokinetics

Journal of Pharmaceutical Sciences, 1971
K B, Bischoff, R L, Dedrick, D S, Zaharko, J A, Longstreth   +3 more
openaire   +2 more sources

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Lancet, The, 2009
Andrés José Maria Ferreri, Reni Michele, Alberto Fabbri   +2 more
exaly  

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

Lancet, The, 2008
Paul Emery, Patrick Durez
exaly  

Methotrexate

1999
openaire   +2 more sources

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Lancet, The, 2014
Josef S Smolen, Paul Emery, Roy M Fleischmann   +2 more
exaly  

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Lancet, The, 1999
Michael H Weisman, Josef S Smolen, Paul Emery   +2 more
exaly  

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

Lancet, The, 2002
Hyon K Choi, Miguel Hernán, James M Robins   +2 more
exaly  

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Roy M Fleischmann, Robert J Moots, Liza Takiya   +2 more
exaly